Sort
4,870 grants matching “glp 1”
Closed-loop neuroelectric control of emesis and gastric motility
$66,000Charles Christopher Horn · University Of Pittsburgh At Pittsburgh · U18 · FY2018 · TR
Mediators of Type 2 Diabetes Mellitus Remission after Gastric Bypass Surgery
$65,778Ankit M Shah · Columbia University Health Sciences · F32 · FY2017 · DK
Role of Novel Branched Chain Fatty Acids in Amelioration of Metabolic Disease
$65,606Meric Erikci Ertunc · Salk Institute For Biological Studies · F32 · FY2019 · DK
Assessing the Role of Glucose-Dependent Insulinotropic Polypeptide to Mediate Improved Beta-Cell Function Following Bariatric Surgery
$65,250Jonathan D. Douros · Duke University · F32 · FY2017 · DK
Appetite Hormones in Binge Eating Disorder
$64,627Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2009 · DK
Amplification of satiation signaling by melanocortin-4 receptors in the nucleus tractus solitarius
$64,310Samantha Fortin · University Of Pennsylvania · F32 · FY2019 · DK
Appetite Hormones in Binge Eating Disorder
$64,261Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2007 · DK
Leptin and development of glucagon-like peptide-1(GLP-1)neural circuits controlling ingestive behavior
$63,034Jessica Erin Biddinger · Vanderbilt University · F32 · FY2018 · DK
Pediatric Type 1 diabetes: Intervention Trials With Glucagon Suppressors
$62,167Rubina A Heptulla · Albert Einstein College Of Medicine · R01 · FY2010 · DK
Malaria Vaccines: Pvs230D1-EPA and PvCSP
$61,964Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
CONTINUED DEVELOPMENT OF RIVAX VACCINE FOR RICIN
$61,801Chad J Roy · Tulane University Of Louisiana · P51 · FY2010 · RR
Developmental Cancer Therapeutics
$61,763David A. Horne · Beckman Research Institute/City Of Hope · P30 · FY2021 · CA
Developmental Cancer Therapeutics
$61,763Miguel Angel Villalona · Beckman Research Institute/City Of Hope · P30 · FY2022 · CA
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes: The B2D Trial
$61,753John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · DK
The Role of Islet DPP4 for Regulation of Glucose Homeostasis
$61,610Megan Capozzi · Duke University · F32 · FY2019 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$61,480Alan Carter · Midwest Research Institute · N01 · FY2023 · DA
Long Acting Native GLP-1 formulations for Type 1 Diabetes
$61,275Elijah M. Bolotin · Pharmain Corporation · R44 · FY2008 · DK
Nutrient-dependent action of glucagon and GLP-1 in glucose metabolism and insulin secretion
$61,226Sarah Marie Gray · Duke University · F32 · FY2019 · DK
Role of Novel Branched Chain Fatty Acids in Amelioration of Metabolic Disease
$61,174Meric Erikci Ertunc · Salk Institute For Biological Studies · F32 · FY2018 · DK
The Impact of Oleoylethanolamide on Glucagon-like Peptide-1 Receptor-Mediated Insulin Secretion and Anorectic Potential
$61,174Jacob Brown · Vanderbilt University · F32 · FY2018 · DK
TOTAL PARENTERAL NUTRITION AND INTESTINAL ADAPTION
$61,110University Of Wisconsin Madison · R01 · FY2005 · DK
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
$60,306James Andrew Hardaway · University Of Alabama At Birmingham · R03 · FY2022 · DK
Biorepository core
$60,133Alash'le G. Abimiku · University Of Ghana · U54 · FY2021 · HL
Developmental Cancer Therapeutics
$60,080David A. Horne · Beckman Research Institute/City Of Hope · P30 · FY2019 · CA
Iron Chelators Predicated on Desferrithiocin
$60,000University Of Florida · R37 · FY2005 · DK